950140 — Englewood Lab Share Price
Last trade - 00:00- KR₩199bn
- KR₩191bn
- $133.59m
- 47
- 50
- 46
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 11.34 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -5.79% | ||
| Dividend Yield (f) | 1.17% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.49 | ||
| Price to Tang. Book | 1.51 | ||
| Price to Free Cashflow | 25.34 | ||
| Price to Sales | 1.09 | ||
| EV to EBITDA | 8.13 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.01% | ||
| Return on Equity | 15.39% | ||
| Operating Margin | 10.31% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 116.24 | 140.52 | 117.27 | 158.41 | 133.59 | 143.32 | 159.32 | 3.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +68.55 | +343.18 | -57.4 | +152.95 | -8.46 | -15.92 | +18.74 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Englewood Lab, Inc. specializes in cosmetics research and development and manufacturing industry. The Company's skincare manufacturing capabilities include a range of oils, creams, serums, cleansers, and masks for various applications. Its hybrid beauty products include primers and foundations, BB and CC Cream (SPF), concealer, blush and illuminizers, bronzer highlighter and lip care. Its over-the-counter products include SPF/acne, personal hygiene, and skin protectant products. The Company’s facilities are specially equipped for producing over-the-counter sunscreen and acne treatment products. With a range of packaging equipment, it can fill bottles, tubes, pumps, boxes, gift packages, and more. It also provides hot-pour products, such as hair products and sample products. The Company provides a variety of services for its clients around the globe.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 20th, 2015
- Public Since
- October 14th, 2016
- No. of Shareholders
- 11,463
- No. of Employees
- 334
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 19,867,866
- Address
- 20 Campus Rd, TOTOWA, 07512
- Web
- http://englewoodlab.com
- Phone
- Auditors
- Daejoo Accounting Corp.
Upcoming Events for 950140
Similar to 950140
Ark Solutions
Korea Exchange - KOSDAQ
Barunson Co
Korea Exchange - KOSDAQ
Bbia Co
Korea Exchange - KOSDAQ
BeautySkin Co
Korea Exchange - KOSDAQ
Bonne Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 20:28 UTC, shares in Englewood Lab are trading at KR₩10,510. This share price information is delayed by 15 minutes.
Shares in Englewood Lab last closed at KR₩10,510 and the price had moved by -23.99% over the past 365 days. In terms of relative price strength the Englewood Lab share price has underperformed the FTSE Developed Asia Pacific Index by -23.12% over the past year.
The overall consensus recommendation for Englewood Lab is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Englewood Lab dividend yield is 0.95% based on the trailing twelve month period.
Last year, Englewood Lab paid a total dividend of $0.07, and it currently has a trailing dividend yield of 0.95%. We do not have any data on when Englewood Lab is to next pay dividends.
We do not have data on when Englewood Lab is to next pay dividends. The historic dividend yield on Englewood Lab shares is currently 0.95%.
To buy shares in Englewood Lab you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩10,510, shares in Englewood Lab had a market capitalisation of KR₩199bn.
Here are the trading details for Englewood Lab:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 950140
Based on an overall assessment of its quality, value and momentum Englewood Lab is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Englewood Lab is KR₩13,622. That is 29.61% above the last closing price of KR₩10,510.
Analysts covering Englewood Lab currently have a consensus Earnings Per Share (EPS) forecast of $0.61 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Englewood Lab. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +1.17%.
As of the last closing price of KR₩10,510, shares in Englewood Lab were trading -5.49% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Englewood Lab PE ratio based on its reported earnings over the past 12 months is 11.34. The shares last closed at KR₩10,510.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Englewood Lab's management team is headed by:
- John Hwa Kim - CEO